Report cover image

Clinical Trial Equipment & Ancillary Solutions Market by Product (Equipment, Services, Systems), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, End-Use, Indication - Global Forecast 2023-2030

Publisher 360iResearch
Published Oct 05, 2023
Length 197 Pages
SKU # IRE18312659

Description

Clinical Trial Equipment & Ancillary Solutions Market by Product (Equipment, Services, Systems), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, End-Use, Indication - Global Forecast 2023-2030


The Clinical Trial Equipment & Ancillary Solutions Market is projected to reach USD 7.62 billion by 2030 from USD 3.88 billion in 2022, at a CAGR of 8.78% during the forecast period.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Clinical Trial Equipment & Ancillary Solutions Market.
  • Based on Product, market is studied across Equipment, Services, and Systems. The Equipment is further studied across Imaging & Diagnostic Equipment and Laboratory Equipment. The Services is further studied across Ancillary Sourcing Services, Data Management & Analysis Services, Maintenance & Calibration Services, Regulatory & Compliance Services, Site Monitoring & Support Services, and Training & Consulting Services. The Ancillary Sourcing Services is further studied across Equipment Leasing & Rental Services, Procurement, and Supply & Logistics. The Systems is further studied across Clinical Trial Management Systems, Electronic Data Capture Systems, and Randomization & Trial Supply Management. The Equipment commanded largest market share of 48.80% in 2022, followed by Services.
  • Based on Type, market is studied across Biologic Drugs, Medical Devices, and Small Molecules. The Medical Devices commanded largest market share of 52.20% in 2022, followed by Biologic Drugs.
  • Based on Phase, market is studied across Phase I, Phase II, Phase III, and Phase IV. The Phase I commanded largest market share of 32.09% in 2022, followed by Phase III.
  • Based on End-Use, market is studied across Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Contract Research Organizations, and Medical Device Companies. The Biotechnology & Pharmaceutical Companies commanded largest market share of 36.54% in 2022, followed by Contract Research Organizations.
  • Based on Indication, market is studied across Blood Disorders, Cardiovascular Diseases, CNS & Mental Disorders, Digestive Disorders, Immunology, Infectious Diseases, Metabolic Disorders, and Oncology. The Immunology commanded largest market share of 18.54% in 2022, followed by Oncology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.35% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Clinical Trial Equipment & Ancillary Solutions Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Clinical Trial Equipment & Ancillary Solutions Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Clinical Trial Equipment & Ancillary Solutions Market, highlighting leading vendors and their innovative profiles. These include Almac Group Limited, Ancillare, LP, Avantor, Inc., Axelerist, B. Braun SE, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Dassault Systèmes SE, Emsere B.V., Eppendorf SE, Eurofins Scientific SE, Global Vision Technologies, Inc., Hitachi, Ltd., IQVIA Holdings Inc., Koninklijke Philips N.V., Lonza Group Ltd., Mednet, Myonex, Inc., Navitas Life Sciences, Oracle Corporation, Parexel International Corporation, Quanticate International Limited, Quipment SAS, Thermo Fisher Scientific, Inc., United Parcel Service, Inc., Veeva Systems Inc., Yokogawa Electric Corporation, and Zifo Technologies Private Limited.

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the Clinical Trial Equipment & Ancillary Solutions Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Clinical Trial Equipment & Ancillary Solutions Market?
  3. What is the competitive strategic window for identifying opportunities in the Clinical Trial Equipment & Ancillary Solutions Market?
  4. What are the latest technology trends and regulatory frameworks in the Clinical Trial Equipment & Ancillary Solutions Market?
  5. What is the market share of the leading vendors in the Clinical Trial Equipment & Ancillary Solutions Market?
  6. Which modes and strategic moves are suitable for entering the Clinical Trial Equipment & Ancillary Solutions Market?


Please Note: PDF & Excel + Online Access - 1 Year

Table of Contents

197 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Clinical Trial Equipment & Ancillary Solutions Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need to determine the safe and effective use of new drugs and medical device
5.1.1.2. Outsourcing of clinical trial activity across the globe
5.1.1.3. Increasing investment in R&D activities for clinical trials equipment & ancillary solutions
5.1.2. Restraints
5.1.2.1. Data security risks associated with cloud-based clinical trial solutions
5.1.3. Opportunities
5.1.3.1. Government initiatives and support for drug development and clinical trials
5.1.3.2. Integration of artificial intelligence (AI) and data analytics in clinical trial solutions
5.1.4. Challenges
5.1.4.1. Complexities in procedures of cross border logistics for clinical trials
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.3.1. Augmenting clinical trials and satisfactory regulatory scenario enlarge the market growth in America
5.3.2. Increasing number of clinical trials and the growing availability of clinical trial equipment & ancillary solutions in the Asia-Pacific region
5.3.3. Advancing clinical trial and drug development infrastructure with encouraging government initiatives in the EMEA region
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Clinical Trial Equipment & Ancillary Solutions Market, by Product
6.1. Introduction
6.2. Equipment
6.3.1. Imaging & Diagnostic Equipment
6.3.2. Laboratory Equipment
6.3. Services
6.4.1. Ancillary Sourcing Services
6.4.2.1. Equipment Leasing & Rental Services
6.4.2.2. Procurement
6.4.2.3. Supply & Logistics
6.4.2. Data Management & Analysis Services
6.4.3. Maintenance & Calibration Services
6.4.4. Regulatory & Compliance Services
6.4.5. Site Monitoring & Support Services
6.4.6. Training & Consulting Services
6.4. Systems
6.5.1. Clinical Trial Management Systems
6.5.2. Electronic Data Capture Systems
6.5.3. Randomization & Trial Supply Management
7. Clinical Trial Equipment & Ancillary Solutions Market, by Type
7.1. Introduction
7.2. Biologic Drugs
7.3. Medical Devices
7.4. Small Molecules
8. Clinical Trial Equipment & Ancillary Solutions Market, by Phase
8.1. Introduction
8.2. Phase I
8.3. Phase II
8.4. Phase III
8.5. Phase IV
9. Clinical Trial Equipment & Ancillary Solutions Market, by End-Use
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Biotechnology & Pharmaceutical Companies
9.4. Contract Research Organizations
9.5. Medical Device Companies
10. Clinical Trial Equipment & Ancillary Solutions Market, by Indication
10.1. Introduction
10.2. Blood Disorders
10.3. Cardiovascular Diseases
10.4. CNS & Mental Disorders
10.5. Digestive Disorders
10.6. Immunology
10.7. Infectious Diseases
10.8. Metabolic Disorders
10.9. Oncology
11. Americas Clinical Trial Equipment & Ancillary Solutions Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Merger & Acquisition
14.3.1.1. RQM+ Acquires Libra Medical
14.3.1.2. Huma acquires Alcedis to expand clinical trial platform
14.3.2. Agreement, Collaboration, & Partnership
14.3.2.1. Lambda Therapeutics partners with Medidata to automate and streamline data management processes for greater clinical trial efficiency
14.3.2.2. Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development
14.3.2.3. Clinical ink Announces Strategic Partnership with Mural Health for New Patient Payment and Logistics Capabilities
14.3.2.4. CardieX Subsidiary ATCOR Partners with Invaryant to Enable Clinical Trials with Advanced New AI Medical Technology
14.3.3. New Product Launch & Enhancement
14.3.3.1. Mednet Launches DICOM Imaging Capabilities Within the iMednet eClinical Platform
14.3.3.2. Cloudbyz Unveils Groundbreaking Electronic Data Capture Solution to Streamline Clinical Research and Accelerate Launch of New Therapies
14.3.3.3. Clario Launches Cloud-Based Image Viewer for Clinical Trials
14.3.3.4. Suvoda launches purpose-built software platform
14.3.3.5. RQM+ Launches Clinical Trial Services
14.3.3.6. Philips launches 12-lead ECG solution for decentralized clinical trials
14.3.4. Investment & Funding
14.3.4.1. Edison Partners leads USD 21 million funding round for clinical trial intelligence disruptor Lokavant
14.3.5. Award, Recognition, & Expansion
14.3.5.1. ClinChoice continues expansion with CRO acquisition
14.3.5.2. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Almac Group Limited
15.1.2. Ancillare, LP
15.1.3. Avantor, Inc.
15.1.4. Axelerist
15.1.5. B. Braun SE
15.1.6. Bio-Rad Laboratories, Inc.
15.1.7. Charles River Laboratories International, Inc.
15.1.8. Dassault Systèmes SE
15.1.9. Emsere B.V.
15.1.10. Eppendorf SE
15.1.11. Eurofins Scientific SE
15.1.12. Global Vision Technologies, Inc.
15.1.13. Hitachi, Ltd.
15.1.14. IQVIA Holdings Inc.
15.1.15. Koninklijke Philips N.V.
15.1.16. Lonza Group Ltd.
15.1.17. Mednet
15.1.18. Myonex, Inc.
15.1.19. Navitas Life Sciences
15.1.20. Oracle Corporation
15.1.21. Parexel International Corporation
15.1.22. Quanticate International Limited
15.1.23. Quipment SAS
15.1.24. Thermo Fisher Scientific, Inc.
15.1.25. United Parcel Service, Inc.
15.1.26. Veeva Systems Inc.
15.1.27. Yokogawa Electric Corporation
15.1.28. Zifo Technologies Private Limited
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us